HOUSTON, July 8, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced various community-driven accolades the Company and its hospitals received in the second quarter of 2025.
Nutex Health hospitals have historically served as the safety net for the communities in which we serve. We believe that the main reason our hospitals are recognized for superior healthcare delivery is our organization's primary focus on patient care. Patients always come first, and our entire organization and its processes revolve around delivering the best patient care possible.
Each award was voted on by their respective communities, demonstrating patient satisfaction and unparalleled service.
Facility Name | Award | Date | Publication |
The Colony ER Hospital | "Best Urgent/Emergency Care" | April 2025 | "Best of the Colony 2025" by The Colony Chamber of Commerce |
Wylie ER | "Best Emergency Room" | April 2025 | C&S Media |
Milwaukee ER & Hospital | "Top Doc Award" – Dr. Michael Brin | June 2025 | Milwaukee Magazine |
Tucson ER & Hospital | "Top Doc Award" – Dr. Maley | June 2025 | Tucson Lifestyle Magazine |
Texarkana Emergency Center & Hospital | "Best Emergency Care/Hospital" | June 2025 | Bowie County Tribune |
Texarkana Emergency Center & Hospital | "Best Emergency Care" | June 2025 | "2025 Best of Texarkana Readers' Choice Awards" by Four States Living Magazine |
Nutex Health Inc. | "Most Admired CEO Honoree" – Dr. Tom Vo | June 2025 | Houston Business Journal |
"We are extremely proud of each and every one of these accolades. They are an affirmation of our work to provide concierge level care to each of the geographical areas that we serve. These awards are also the reason why we are the preferred hospitals for a lot of the family members of physicians and other healthcare providers in the communities," said Tom Vo, M.D., MBA, Chairman and Chief Executive Officer of Nutex Health.
About Nutex Health Inc.
Headquartered in Houston, Texas and founded in 2011, Nutex Health Inc. (NASDAQ: NUTX) is a healthcare management and operations company with two divisions: a Hospital Division and a Population Health Management Division.
The Hospital Division owns, develops and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates 24 facilities in 11 states.
The Population Health Management division owns and operates provider networks such as Independent Physician Associations (IPAs). Through our Management Services Organization (MSO), we provide management, administrative and other support services to our affiliated hospitals and physician groups.
Forward-Looking Statements
Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases "will", "will likely result," "expected to," "will continue," "anticipated," "estimate," "projected," "intend," "goal," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include, but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, including the interim final and final rules implemented under the No Surprises Act, economic conditions, dependence on management, dilution to stockholders, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company's ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed in the Annual Report on Form 10-K for the year ended December 31, 2024, and subsequent Quarterly Report on Form 10-Q for the three months ended March 31, 2025 under the heading "Risk Factors" in Part II, Item IA thereof, and other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release.
Last Trade: | US$130.11 |
Daily Change: | 4.37 3.48 |
Daily Volume: | 187,743 |
Market Cap: | US$723.380M |
March 20, 2025 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load